The purpose of this work was to develop a 3D BB ME T2* Imaging technique to to allow quantitative ferumoxytol imaging on delayed scans by measuring T2* in intracranial atherosclerotic plaque(ICAD). Post-gadoliniun enhancement in ICAD may be related to endothelial dysfunction or breakdown or secondary to plaque inflammation. Delayed ferumoxytol imaging allows intravascular clearance with retention in the macrophages present in vulnerable atherosclerotic plaque. We developed a 3D BB ME T2* imaging technique to allow quantitative ferumoxytol imaging on delayed scans by measuring T2* in ICAD.
This abstract and the presentation materials are available to members only; a login is required.